Bromide

Bromide

SCHEMBL2395819

C=C[n+]1ccn(CCCCCCCC)c1.[Br-]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.60
HSP90AA1 P07900 2/20 0.60
KMT2A Q03164 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
APAF1 O14727 1/20 0.60
NPC1 O15118 1/20 0.60
PLA2G1B P04054 1/20 0.60
MAPT P10636 1/20 0.60
MAPK1 P28482 1/20 0.60
HTT P42858 1/20 0.60
RAB9A P51151 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
ATG4B Q9Y4P1 1/20 0.60
FDPS P14324 17/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2395832 1.00 MEN1 (0.60) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Bromide SCHEMBL2396034 1.00 MEN1 (0.60) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Bromide SCHEMBL2395867 1.00 MEN1 (0.60) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Bromide SCHEMBL2399324 1.00 MEN1 (0.60) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Bromide SCHEMBL2395677 1.00 MEN1 (0.60) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Bromide SCHEMBL2395709 1.00 MEN1 (0.60) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL16307692 0.98 MEN1 (0.57) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL31501079 0.98 MEN1 (0.57) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL27921181 0.98 MEN1 (0.57) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL8450143 0.98 MEN1 (0.57) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111811702-A High-recovery conductive film pressure sensor and preparation method thereof 无锡康森斯克电子科技有限公司 2020-10-23 CN claimed
CN-110975939-A Ethylene carbonate hydrogenation heterogeneous catalyst, and preparation method and application thereof 华东师范大学 2020-04-10 CN claimed
US-20250135435-A1 SYSTEM FOR BATCH SCALE PRODUCTION OF EXTRACTION SORBENTS WITH 3D PRINTING AND ASSOCIATED METHOD OF USE IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2025-05-01 US disclosed
CN-115894973-A Preparation method of novel dual-network self-healing hydrogel sensor 南京林业大学 2023-04-04 CN disclosed
CN-114891167-A Binary ionic liquid covalent bonding immobilized silicon-based material and preparation and application thereof 武汉理工大学 2022-08-12 CN disclosed
CN-109503780-B Antibacterial hydrogel material and preparation method and application thereof 大连医诺生物股份有限公司 2021-06-18 CN disclosed
CN-108689838-B Method for preparing formic ether by catalyzing esterification of formic acid and olefin through swellable acidic polyion liquid 华东师范大学 2021-05-25 CN disclosed
CN-108579807-B Cross-linked polymerization acidic ionic liquid alkylation catalyst and preparation method thereof 江苏棋成化工有限公司 2021-03-23 CN disclosed
CN-108929344-B Method for separating phospholipid monomers in phospholipid homologues through polyion liquid 浙江大学 2021-01-08 CN disclosed
CN-111811702-A High-recovery conductive film pressure sensor and preparation method thereof 无锡康森斯克电子科技有限公司 2020-10-23 CN disclosed
CN-110975939-A Ethylene carbonate hydrogenation heterogeneous catalyst, and preparation method and application thereof 华东师范大学 2020-04-10 CN disclosed
US-9837181-B2 Processes for nanoparticle dispersions with ionic liquid-based stabilizers EASTERN MICHIGAN UNIVERSITY (US) 2017-12-05 US disclosed
US-9017716-B2 Ophthalmic lens MENICON CO., LTD. (JP) 2015-04-28 US disclosed
US-20150086721-A1 PROCESSES FOR NANOPARTICLE DISPERSIONS WITH IONIC LIQUID-BASED STABILIZERS EASTERN MICHIGAN UNIVERSITY 2015-03-26 US disclosed
US-8920682-B2 Nanoparticle dispersions with ionic liquid-based stabilizers EASTERN MICHIGAN UNIVERSITY (US) 2014-12-30 US disclosed
US-20120148519-A1 OPHTHALMIC LENS MENICON CO., LTD. (JP) 2012-06-14 US disclosed
EP-2453293-A1 OPHTHALMIC LENS Menicon Co., Ltd. (JP) 2012-05-16 EP disclosed
US-20110233458-A1 Nanoparticle dispersions with ionic liquid-based stabilizers EASTERN MICHIGAN UNIVERSITY Office of Research Development (US) 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120148519-A1 OPHTHALMIC LENS AQP4, CRYAA, UACA MEN1 2152/4885HSP90AA1 959/4885KMT2A 1875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.